Answers are grounded in this paper and cite their sources.
Pulmonary aspiration of gastric contents remains a leading cause of anaesthesia-related morbidity and mortality. Risk factors for increased residual gastric contents are recognised, but the association with neoadjuvant chemotherapy (NACT) has received limited direct clinical evaluation. This study aimed to use gastric ultrasound to evaluate whether prior NACT is associated with increased residual gastric contents in patients undergoing elective breast surgery. This single-centre prospective observational study compared gastric ultrasound findings between patients with breast cancer who received NACT and chemotherapy-naïve controls with benign or malignant breast disease. Gastric contents were assessed by point-of-care ultrasound (POCUS) after standard fasting. The primary outcome was the proportion of increased residual gastric contents, defined as gastric volume > 1.5 mL/kg or presence of solid content. Multivariable logistic regression was used to identify independent predictors. A sensitivity analysis using a threshold of > 2.3 mL/kg was performed. A total of 247 patients were included in the final analysis (122 in NACT group, 125 in control group). The proportion of patients with increased residual gastric contents was 32.0% in the NACT group versus 17.6% in the control group ( P = 0.009). The NACT group demonstrated larger antral cross-sectional area (7.04 vs. 6.17 cm²; P = 0.002), greater gastric volume (63.09 vs. 53.96 mL; P = 0.014), and more frequent solid contents (16.4% vs. 7.2%; P = 0.025). Prior NACT (OR 2.27, 95% CI 1.21–4.28; P = 0.011) and shorter fluid fasting duration were independently associated with increased residual gastric contents; younger age was also associated with this outcome, although age-dependent volume estimation may have contributed to the association. The NACT group had a higher proportion of ultrasound-defined increased residual gastric contents after standard fasting than the non-NACT controls. POCUS may serve as a useful adjunct for identifying patients with elevated residual gastric contents. ChiCTR2500098662(registration date: 12 March 2025).
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: